The performance of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key regions has introduced substantial uncertainty . Investors are now facing the consequences of rival med